Vertex Pharmaceuticals Incorporated (ETR:VX1)
394.20
-11.50 (-2.83%)
Jan 12, 2026, 9:51 AM CET
Vertex Pharmaceuticals Employees
Vertex Pharmaceuticals had 6,100 employees as of December 31, 2024. The number of employees increased by 700 or 12.96% compared to the previous year.
Employees
6,100
Change (1Y)
700
Growth (1Y)
12.96%
Revenue / Employee
€1,637,995
Profits / Employee
€513,490
Market Cap
101.18B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6,100 | 700 | 12.96% |
| Dec 31, 2023 | 5,400 | 600 | 12.50% |
| Dec 31, 2022 | 4,800 | 900 | 23.08% |
| Dec 31, 2021 | 3,900 | 500 | 14.71% |
| Dec 31, 2020 | 3,400 | 400 | 13.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,784 |
Vertex Pharmaceuticals News
- 3 days ago - $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth This Much Today - Benzinga
- 4 days ago - Vertex Pharmaceuticals: The Cost Of Growing Beyond Cystic Fibrosis (Rating Downgrade) - Seeking Alpha
- 4 days ago - UBS Lowers Price Target for Vertex Pharmaceuticals (VRTX) to $535.00 | VRTX Stock News - GuruFocus
- 5 days ago - Wolfe Research Upgrades Vertex Pharmaceuticals (VRTX) to Outperform | VRTX Stock News - GuruFocus
- 6 days ago - My 10 Top Stocks to Buy to Start the New Year Off Right - The Motley Fool
- 6 days ago - A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings - Benzinga
- 11 days ago - The Best Stocks to Invest $1,000 in to Start the New Year Off Right - The Motley Fool
- 11 days ago - When Phase 3 Data Drops, What Determines A Sustained Rally Vs. A Fading Initial Pop - Benzinga